(Q44406412)

2 December 2017

title

5-imidazolyl-quinolinones, -quinazolinones and -benzo-azepinones as farnesyltransferase inhibitors (English)

1 reference

2 December 2017

Patrick Angibaud

1

1 reference

2 December 2017

Xavier Bourdrez

2

1 reference

2 December 2017

Ann Devine

3

1 reference

2 December 2017

David W End

4

1 reference

2 December 2017

Eddy Freyne

5

1 reference

2 December 2017

Yannick Ligny

6

1 reference

2 December 2017

Philippe Muller

7

1 reference

2 December 2017

Geert Mannens

8

1 reference

2 December 2017

Isabelle Pilatte

9

1 reference

2 December 2017

Virginie Poncelet

10

1 reference

2 December 2017

Stacy Skrzat

11

1 reference

2 December 2017

Gerda Smets

12

1 reference

2 December 2017

Jacky Van Dun

13

1 reference

2 December 2017

Pieter Van Remoortere

14

1 reference

2 December 2017

Marc Venet

15

1 reference

2 December 2017

Walter Wouters

16

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

2 December 2017

published in

1 reference

2 December 2017

volume

13

1 reference

2 December 2017

issue

9

1 reference

2 December 2017

page(s)

1543-1547

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

2 December 2017

1 reference

7 January 2021

Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Inhibition of farnesyltransferase increases TGFbeta type II receptor expression and enhances the responsiveness of human cancer cells to TGFbeta.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900180-X

7 January 2021

10.1016/S0960-894X(03)00180-X

Identifiers

DOI

1 reference

2 December 2017

1 reference